{"type":"img","src":"https://cdn.quv.kr/dftb6ow8k%2Fup%2F5c32ea85dae40_1920.png","height":90}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US
    • {"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Noto Sans KR","Nanum Barun Gothic"]}
    LOGO
    ×
    섹션 설정
    {"type":"img","src":"https://cdn.quv.kr/dftb6ow8k%2Fup%2F5c32ea85dae40_1920.png","height":50}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US

    • OUR COMPANY

    Company Introduction

    2022

    01 Selected BIG3 Innovation Startup Package by the Ministry of SMEs and Startups

    03 Certification of Inno-Biz

    04 Selected to be a 2022 regular membership(Global) of Shinhan Square Bridge Incheon

    05 Attracted investment from Korea Venture Fund

           Certification of Small Giant Corporate by the Ministry of Employment and Labor

    2021

    01 Headquarters relocation (Incheon Startup Park)

    04 Licensed-out RCI001 to Hanlim pharmaceutical Co. for domestic rights 

    07 RCI002 PCT and US Patent Application

    08 RudaCure U.S.A. Establishment of U.S. Corporate

    09 Selected to be part of Bio I-Corps Program by the Minister of Science & Technology

           Attracted investments from Y&Archer and other individual investors

    10 Two trademark registrations

    11 Venture Investment Association (CKD Startup Investment) to attract investment

    12 RCI002 Domestic Patent Registration
           Atopic dermatitis/AMD before extension of applicability
           Full-time Toxicity and Effectiveness Test Research Service Expansion

    2020

    01 RCI002 Domestic Patent Application

    02 Selection of RCI001 New Research Projects

    06 RCI001 US Patent Registry

    11 RCI002 PCT Application and US Patent Application

     

    RCI003
    Atopic dermatitis drug screening and optimization
    RCI004
    metastatic cancer treatment drug screening

    2019

    01 Accreditation of the Institute of Corporate Affiliated Research Institut

    03 Agreement on Small and Medium Venture Performance Sharing Companies

    05 Certification of Venture Businesses

    11 Attract investment in technology guarantee

    12 Headquarters Extension

    2018

    07.27 Establishment of Rudacure co., ltd.

    {"google":["Noto Sans","Poppins","Roboto","Oswald"],"custom":["Noto Sans KR","Nanum Square","Nanum Barun Gothic","Jeju Gothic"]}{"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Nanum Barun Gothic","Noto Sans KR","Jeju Gothic"]}


    Company Name  RudaCure Co., Ltd

    CEO  Yong Ho Kim ｜ CPO  Seunghoon Kim
    Location  HQ: R316, InstarⅠ, 204, Convensia-daero, Yeonsu-gu, Incheon, Republic of Korea
    Research Institute : R302, BRC1, 9, Songdomirae-ro, Yeonsu-gu, Incheon, Republic of Korea
    US Office 40W, 37th St. Suite 801 New York, NY 10018
    Corportate registration number  548-86-00995
    COPYRIGHT (C) LOGO. All Rights reserved

    Company Name  RudaCure Co., Ltd ｜ CEO  Yong Ho Kim ｜ CPO  Seunghoon Kim
    Location  
    HQ R316, InstarⅠ, 204, Convensia-daero, Yeonsu-gu, Incheon, Republic of Korea
    Research Institute  R302, BRC1, 9, Songdomirae-ro, Yeonsu-gu, Incheon, Republic of Korea
    Seoul Office R1001, 145, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea
    US Office 40W, 37th St. Suite 801 New York, NY 10018
    Corportate registration number  548-86-00995

    COPYRIGHT (C) RUDACURE. All Rights reserved

    {"google":[],"custom":["Noto Sans KR","Jeju Gothic"]}